ITOS iTeos Therapeutics, Inc.: institutional ownership and insider trading
1 funds reported holding $464K of iTeos Therapeutics, Inc. in their latest 13F filings; in Q4 2025 funds net bought $0, with 0 new positions and 1 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Largest institutional holders of ITOS
- Nuveen Asset Management, LLC — $464K
Recent ITOS insider trades
- Jun 10, 2025: Detheux Michel sold 104,565 shares ($1.05M)
- Jun 6, 2025: Detheux Michel sold 156,847 shares ($1.59M)
- Jun 6, 2025: Hallal David sold 114,682 shares ($1.16M)
- May 15, 2025: EcoR1 Capital, LLC bought 4,958,978 shares ($38.7M)
5%+ owners
- TANG CAPITAL MANAGEMENT, LLC: 100.0% (Schedule 13D/A, filed Sep 3, 2025)
- EcoR1 Capital, LLC: 27.9% (Schedule 13D, filed May 16, 2025)
- BVF PARTNERS L P/IL: 8.1% (Schedule 13G/A, filed May 15, 2025)
- BlackRock Portfolio Management LLC: 6.1% (Schedule 13G, filed Apr 15, 2025)
- BlackRock, Inc.: 5.7% (Schedule 13G/A, filed Apr 23, 2025)